Product Information
DROXIDOPA 300 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.6037 per EA under NDC 63304011290. Its NADAC has been published 140 times since Jun 21, 2023.
The High Outlier badge above means this manufacturer's average price in the droxidopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 ug/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304011290
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214384On Market Since
2/18/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 300 MG CAPSULE has been published 140 times since Jun 21, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6037 per EA |
|---|---|
| All-time high | $3.0478 (Nov 13, 2024) |
| All-time low | $2.1966 (Sep 17, 2025) |
| 52-week high | $2.6037 |
| 52-week low | $2.1966 |
| Median price | $2.5551 |
| Average price | $2.5628 |
| Largest weekly change | +12.0% (Aug 21, 2024) |
| Weeks tracked | 140 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $2.6037 per EA (NDC 63304011290), effective Feb 18, 2026.
How has the price of DROXIDOPA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 140 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $2.1966 (Sep 17, 2025) to a high of $3.0478 (Nov 13, 2024), with a median of $2.5551 per EA.
Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROXIDOPA 300 MG CAPSULE, is $2.2477 per EA — about 14% below DROXIDOPA 300 MG CAPSULE.
Who manufactures DROXIDOPA 300 MG CAPSULE?
DROXIDOPA 300 MG CAPSULE (NDC 63304011290) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification